OncoAlert
@OncoAlert
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨
ID:1109128247789395968
http://www.OncoAlert360.com 22-03-2019 16:22:35
90,4K Tweets
34,7K Followers
159 Following
Follow People
Toni Choueiri, MD
Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow @GMA
Vivek Subbiah, MD
Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Matteo Lambertini, MD PhD
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Chair of @myESMO YOC. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.
Stephen V Liu, MD
Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Host @IASLC Podcast; Chair #TexasLung24 #PLCCLive24 #DCLung24 #HereWeGo
ESMO - Eur. Oncology
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
Interesting multi-omic analysis of previously classified SCLC cell lines (YAP1+), identifies that these tumors represent diseases that ‘mimic’ SCLC- in this case- SMARCA4-deficient thoracic tumors, that have a poor prognosis
Clinical Cancer Research OncoAlert #LCSM
aacrjournals.org/clincancerres/…
Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy
By Nausheen Ahmed MD Zahra M, PharmD, MBA, BCOP, FHOPA KU Cancer Center
OncoAlert #MedEd #medtwitter IACH #mmsm #myeloma USMIRC News
chi.scholasticahq.com/article/115932…
The MONARCH 3 trial
Addition of abemaciclib to a nonsteroidal aromatase inhibitor (NSAI) as initial therapy for hormone receptor-positive, 🧬HER2-negative advanced #BreastCancer
✅ Significantly improved PFS and showed clinically meaningful improvement in OS
➡️ particularly…
The Lancet Commission highlights the urgent need to address the projected doubling of global #ProstateCancer cases by 2040
Doing so by:
✅Early diagnosis strategies
✅Equitable access to care
@oncoAlert 🚨
Thanks for sharing Ashish M. Kamat, MD, MBBS the APPs have indeed major role & huge contributions in patient care, research, education, outreach, etc. Amer. Urol. Assn. MD Anderson Cancer Center
Fred Hutchinson Cancer Center UW Urology OncoAlert UroToday.com Sarah P. Psutka MD MS Dimitra Bakaloudi MD, MS Dr. Bishoy M. Faltas Shilpa Gupta Pavlos Msaouel
#WorldOvarianCancerDay please remember BEACH signs and spread the word! Ovarcome Ovarian Cancer Research Alliance Runsi Ayona Sen SoMe4GynOnc World Gynecologic Oncology Day OncoAlert
An encouraging development for #BRAF mutant #lungcancer in Cancer Discovery. Responses seen in pretreated pts with class 1 BRAF mutations (V600E) at full dose. Less efficacy for class II/III, though lower doses used. OncoAlert #LCSM Chat Open Oncology